Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
Medical Legal
Penalized for “On-Label” Marketing? In Wake of Amarin, Pacira…
Last week, Pacira Pharmaceuticals, Inc. filed a lawsuit against the Food and Drug Administration (FDA) seeking to…
Quest Diagnostics Pay $1.79 Million To Settle False Claims Act Allegations
Last week, the Justice Department announced that Quest Diagnostics Inc. and Quest Diagnostics Clinical Laboratories…
New Report Looks At Intersection of “Medical Lending” and…
A recent article in Reuters shed an interesting and potentially disturbing light on the “medical lending” industry,…
Purdue Pharma Settles With New York AG Over Oxycontin Promotion; Agrees To…
New York’s Attorney General recently announced an agreement with Purdue Pharma, the manufacturer of OxyContin, that…
Amgen Pays $71 Million to States For Off-Label Allegations In Violation of…
Earlier this week, Amgen Inc. agreed to pay $71 million to 48 states to settle allegations that it violated state consumer…
OIG Continues Scrutiny of Physician-Owned Distributors of Spinal Devices…
Last week, the Department of Health and Human Services Office of Inspector General (OIG) followed up on its recent…
Amarin Wins Preliminary Injunction Against FDA To Promote Truthful…
On Friday, a New York Federal Judge ruled that Amarin Pharma is allowed to promote Vascepa, the company's Omega 3…
NuVasive Inc. Agrees to $13.5 Million False Claims Act Settlement
Late last week, the Department of Justice announced that California-based medical device manufacturer NuVasive Inc.…
Avoiding Medicare Fraud & Abuse: A Roadmap for Physicians
The Centers for Medicare and Medicaid Services (CMS) published a “roadmap for physicians” to submit proper claims for…
District Court Holds Corporate Integrity Agreement Obligations May Create…
Last week, U.S. District Court Judge Thomas O’Neill of the Eastern District of Pennsylvania denied Cephalon’s motion to…